Viewing nowDonepezil Tablet 5 mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 5.22mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200605446 · Notified 2006.06.16 · Insurance code 643500340
Treatment of symptoms of Alzheimer-type dementia
This medication is used to treat symptoms of Alzheimer's dementia. It helps improve dementia-related symptoms such as memory impairment and cognitive dysfunction, enhancing the quality of daily life.
Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this drug may be considered. Because donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with attention to gastrointestinal adverse reactions. If administration of this drug is discontinued, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. Female patients aged 85 years or older with low body weight: Because adverse reactions occur frequently, careful monitoring is required. Elderly women with low body weight should not exceed 5 mg daily.
Pediatric patients: There is no experience with use in pediatric patients.
This medication contains Donepezil Hydrochloride Hydrate as its active ingredient and is used to treat symptoms of Alzheimer's dementia. Firstly, this medication should not be administered to certain patients. For example, individuals who are allergic to this medication, its components, or similar medications, pregnant women or those who may become pregnant, breastfeeding women, and those with lactose intolerance or specific genetic metabolic disorders should not use this medication. Additionally, individuals with heart disease or conduction disorders must be cautious, as this medication may slow heart rate or cause arrhythmia. Those with a history of gastric ulcers or currently taking anti-inflammatory analgesics should also be careful, as gastrointestinal issues may worsen. Patients with respiratory diseases such as asthma or chronic obstructive pulmonary disease should use this medication cautiously, as it may cause bronchoconstriction or increase mucus secretion, worsening symptoms. Patients with extrapyramidal disorders such as Parkinson's disease also need to be cautious, as symptoms may worsen. While taking this medication, various adverse reactions may occur. Issues related to the heart, gastrointestinal bleeding, liver dysfunction, cerebrovascular problems, neurological issues, muscle problems, and dyspnea have been reported, and in severe cases, medication should be stopped immediately, and medical attention should be sought. Commonly, symptoms such as nausea, vomiting, diarrhea, decreased appetite, dizziness, and insomnia may occur. Adverse reactions may vary depending on the patient's condition, so continuous monitoring of status during treatment is necessary. This medication has not been approved for use in other forms of dementia or cognitive impairment and treatment should be conducted under the supervision of an experienced physician. If there is no therapeutic effect or if side effects are severe, discontinuation should be considered. Additionally, since this medication can affect heart rate, patients with heart disease or electrolyte imbalances may need ECG monitoring. Those with a history of gastrointestinal disorders should also be monitored closely to prevent symptom deterioration. Caution is needed when driving or operating machinery, as symptoms such as dizziness or drowsiness may occur. This medication is primarily metabolized in the liver, so patients with impaired liver function should also be cautious, and its use should be avoided by pregnant or breastfeeding women. Drug interactions must also be considered. Co-administration with certain antibiotics, antidepressants, and antiarrhythmics may alter the effects of this medication, so consultation with a physician or pharmacist is essential. In case of overdose, symptoms such as nausea, vomiting, bradycardia, and respiratory distress may occur, and immediate medical attention is required; atropine may be used as an antidote. Finally, this medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is essential to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's effectiveness and safety.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 5.22mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.